DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial

Phase 2

Completed

Conditions: Central Neuropathic Pain
Allodynia
Spinal Cord Injury

Interventions: Drug: Placebo (Dextromethorphan)
Drug: Lidocaine
Drug: Dextromethorphan
Drug: Placebo (Lidocaine)

First Posted Date: 2014-08-18

Last Posted Date: 2018-03-22

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 26

Registration Number: NCT02218203

Locations: 🇺🇸
Translational Pain Research, Brigham and Women's Hospital, Boston, Massachusetts, United States

Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

Early Phase 1

Terminated

Conditions: Subarachnoid Hemorrhage

Interventions: Drug: desferrioxamine (DFO)
Drug: placebo

First Posted Date: 2014-08-15

Last Posted Date: 2015-07-21

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 2

Registration Number: NCT02216513

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury

Completed

Conditions: Acute Kidney Injury

First Posted Date: 2014-07-25

Last Posted Date: 2015-07-21

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 150

Registration Number: NCT02200120

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Combined Medication for Improved Analgesia in Superficial Pain

Phase 3

Completed

Conditions: Pain

Interventions: Drug: Placebo
Drug: Diclofenac and Atropine combination drug

First Posted Date: 2014-07-18

Last Posted Date: 2018-07-03

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 100

Registration Number: NCT02194088

Locations: 🇺🇸
Brigham And Women's Hospital, Boston, Massachusetts, United States

Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients

Conditions: Indication for Care or Intervention Related to Labor or Delivery With Baby Delivered

First Posted Date: 2014-07-17

Last Posted Date: 2022-08-03

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 400

Registration Number: NCT02193542

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?

Not Applicable

Completed

Conditions: Abnormal Uterine Bleeding
Pelvic Pain
Adenomyosis
Uterine Fibroids

Interventions: Device: Storz 3D Laparoscopy System
Device: 2D Laparoscopy

First Posted Date: 2014-07-17

Last Posted Date: 2018-01-24

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 57

Registration Number: NCT02192606

Locations: 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
🇩🇰
Odense University Hospital, Odense, Denmark

Tau Imaging of Chronic Traumatic Encephalopathy

Phase 2

Completed

Conditions: Chronic Traumatic Encephalopathy

Interventions: Radiation: [F18]-T807
Radiation: [F18]-Florbetapir
Device: MRI/MRS
Genetic: Genetic Analysis for Genetic Risk Score for Tau.

First Posted Date: 2014-07-16

Last Posted Date: 2018-05-17

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 30

Registration Number: NCT02191267

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Boston University Medical Center, Boston, Massachusetts, United States

Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient

Phase 4

Completed

Conditions: Diabetes Mellitus

Interventions: Drug: Saxagliptin

First Posted Date: 2014-07-08

Last Posted Date: 2017-06-23

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 72

Registration Number: NCT02182895

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

VITAL Rhythm Study

Phase 3

Conditions: Cardiovascular Disease

Interventions: Dietary Supplement: Vitamin D3
Drug: Omega-3 fatty acids (fish oil)
Dietary Supplement: Fish oil placebo
Dietary Supplement: Vitamin D3 placebo

First Posted Date: 2014-06-30

Last Posted Date: 2022-07-21

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 25119

Registration Number: NCT02178410

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism

Not Applicable

Completed

Conditions: Aging
Circadian Disruption
Sleep Restriction

Interventions: Behavioral: Sleep Restriction
Behavioral: Control
Behavioral: Circadian Disruption

First Posted Date: 2014-06-24

Last Posted Date: 2019-08-20

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 21

Registration Number: NCT02171273

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy